Familial chylomicronemia syndrome (#FCS) is a rare, genetic disease that prevents the body from breaking down fats. It can significantly impact patients’ lives through a range of symptoms including extreme fatigue and frequent stomach and back pain, which may lead to potentially life-threatening acute pancreatitis. In this video, hear from Rick, who is living with FCS, about what it's like to experience these symptoms. | Ionis Pharmaceuticals | Facebook

Gamifant (emapalumab) is now FDA-approved as the first treatment for macrophage activation syndrome in Still’s disease. Learn how this IFNγ-targeting antibody could change care for patients by Soumya Shashikumar at https://buff.ly/w6L0pZi. | Xtalks Webinars